Abstract
•Designers and systematic reviewers of trials are advised to consider characteristics that may minimize risk of bias in trial results. •To date, trial characteristics recommended for consideration have been selected on the basis of empirical evidence (eg, meta-epidemiological studies) and theoretical considerations. •Herbert raises legitimate concerns about risk of bias due to confounding in the meta-epidemiological evidence underpinning these recommendations. •However, additional limitations in the evidence base also deserve attention, including misclassification of trial characteristics, nonreporting biases affecting the pool of trials available for analysis, and the generalizability of the meta-analyses sampled.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.